Long-term therapy with Bevacizumab in a young patient affected by NF2. Stop or continue treatment? An update of a case report and review of the literature
Olga Nigro(Fondazione IRCCS Istituto Nazionale dei Tumori), Graziella Pinotti(Medica (Italy)), I. Vallini(Ospedale di Circolo e Fondazione Macchi), Andrea Coppola(University of Insubria), Tiziana Tartaro(Ospedale di Circolo e Fondazione Macchi), Alessandro Tuzi(Ospedale di Circolo e Fondazione Macchi)
Cited by 4
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684